Mechanisms of peripheral levodopa resistance in Parkinson’s disease

por Beckers, Milan, Bloem, Bastiaan R., Verbeek, Marcel M.
Publicado 2022

Aromatic L-Amino acid decarboxylase deficiency: A new case from Turkey with a novel mutation

por Gücüyener, Kıvılcım, Kasapkara, Çiğdem Seher, Tümer, Leyla, Verbeek, Marcel M.
Publicado 2014

A multifunctional ELISA to measure oxidised proteins: oxPin1 in Alzheimer's brain as an example

por Herbert, Megan K., Verbeek, Marcel M., Küsters, Benno, Kuiperij, H. Bea
Publicado 2015

Aβ43 in human Alzheimer’s disease: effects of active Aβ42 immunization

por Jäkel, Lieke, Boche, Delphine, Nicoll, James A. R., Verbeek, Marcel M.
Publicado 2019

Heat Shock Proteins and Amateur Chaperones in Amyloid-Beta Accumulation and Clearance in Alzheimer’s Disease

por Wilhelmus, Micha M. M., de Waal, Robert M. W., Verbeek, Marcel M.
Publicado 2007

Cerebrospinal Fluid Glucose and Lactate: Age-Specific Reference Values and Implications for Clinical Practice

por Leen, Wilhelmina G., Willemsen, Michèl A., Wevers, Ron A., Verbeek, Marcel M.
Publicado 2012

LRP1 shedding in human brain: roles of ADAM10 and ADAM17

por Liu, Qiang, Zhang, Juan, Tran, Hien, Verbeek, Marcel M, Reiss, Karina, Estus, Steven, Bu, Guojun
Publicado 2009

Views on the Desirability of Diagnosing Sporadic Cerebral Amyloid Angiopathy with Biological Evidence

por Abdulrahman, Herrer, Smedinga, Marthe, Verbeek, Marcel M., Klijn, Catharina J.M., Richard, Edo, Perry, Marieke
Publicado 2022

MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid

por Müller, Mareike, Jäkel, Lieke, Bruinsma, Ilona B., Claassen, Jurgen A., Kuiperij, H. Bea, Verbeek, Marcel M.
Publicado 2015

Valuing biomarker diagnostics for dementia care: enhancing the reflection of patients, their care-givers and members of the wider public

por van der Burg, Simone, Schreuder, Floris H. B. M., Klijn, Catharina J. M., Verbeek, Marcel M.
Publicado 2019

Reduced Influence of apoE on Aβ43 Aggregation and Reduced Vascular Aβ43 Toxicity as Compared with Aβ40 and Aβ42

por Jäkel, Lieke, Biemans, Elisanne A.L.M., Klijn, Catharina J.M., Kuiperij, H. Bea, Verbeek, Marcel M.
Publicado 2020

Blood, urine and cerebrospinal fluid analysis in TH and AADC deficiency and the effect of treatment

por Wassenberg, Tessa, Geurtz, Ben P.H., Monnens, Leo, Wevers, Ron A., Willemsen, Michèl A., Verbeek, Marcel M.
Publicado 2021

Limitations of the hCMEC/D3 cell line as a model for Aβ clearance by the human blood‐brain barrier

por Biemans, Elisanne A.L.M., Jäkel, Lieke, de Waal, Robert M.W., Kuiperij, H. Bea, Verbeek, Marcel M.
Publicado 2016

Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis

por Jäkel, Lieke, De Kort, Anna M., Klijn, Catharina J.M., Schreuder, Floris H.B.M., Verbeek, Marcel M.
Publicado 2021

Increased plasma amyloid-β(42) protein in sporadic inclusion body myositis

por Abdo, Wilson F., van Mierlo, Tom, Hengstman, Gerald J., Schelhaas, H. Jurgen, van Engelen, Baziel G., Verbeek, Marcel M.
Publicado 2009

α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism

por van Rumund, Anouke, Green, Alison J. E., Fairfoul, Graham, Esselink, Rianne A. J., Bloem, Bastiaan R., Verbeek, Marcel M.
Publicado 2019

Factors associated with mortality in early stages of parkinsonism

por van Rumund, Anouke, Esselink, Rianne A. J., Berrevoets-Aerts, Marjolein B., Otto, Markus, Bloem, Bastiaan R., Verbeek, Marcel M.
Publicado 2022

Parkinson’s Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism

por van Rumund, Anouke, Aerts, Marjolein B., Esselink, Rianne A. J., Meijer, Frederick J. A., Verbeek, Marcel M., Bloem, Bastiaan R.
Publicado 2018

Inhibition of Neuroinflammation May Mediate the Disease-Modifying Effects of Exercise: Implications for Parkinson’s Disease

por Darweesh, Sirwan K.L., De Vries, Nienke M., Helmich, Rick C., Verbeek, Marcel M., Schwarzschild, Michael A., Bloem, Bastiaan R.
Publicado 2022

Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer's Disease in Clinical Practice: An Illustration with 3 Case Reports

por Slats, Diane, Spies, Petra E., Sjögren, Magnus J.C., Verhey, Frans R.J., Verbeek, Marcel M., Olde Rikkert, Marcel G.M.
Publicado 2010